Antonio Coluccia

3.7k total citations
73 papers, 2.7k citations indexed

About

Antonio Coluccia is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Antonio Coluccia has authored 73 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 29 papers in Organic Chemistry and 24 papers in Infectious Diseases. Recurrent topics in Antonio Coluccia's work include HIV/AIDS drug development and treatment (18 papers), Synthesis and biological activity (15 papers) and HIV Research and Treatment (12 papers). Antonio Coluccia is often cited by papers focused on HIV/AIDS drug development and treatment (18 papers), Synthesis and biological activity (15 papers) and HIV Research and Treatment (12 papers). Antonio Coluccia collaborates with scholars based in Italy, United Kingdom and United States. Antonio Coluccia's co-authors include Romano Silvestri, Giuseppe La Regina, Andrea Brancale, Marino Artico, Gabriella Martino, Ettore Novellino, Ernest Hamel, Michael Edler, Maria Chiara Barbera and Giovanni Maga and has published in prestigious journals such as PLoS ONE, Oncogene and Scientific Reports.

In The Last Decade

Antonio Coluccia

70 papers receiving 2.6k citations

Peers

Antonio Coluccia
Lan Xie China
Jay Wrobel United States
S.K. Puri India
John Proudfoot United States
F. George Njoroge United States
Antonio Coluccia
Citations per year, relative to Antonio Coluccia Antonio Coluccia (= 1×) peers Giuseppe La Regina

Countries citing papers authored by Antonio Coluccia

Since Specialization
Citations

This map shows the geographic impact of Antonio Coluccia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Coluccia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Coluccia more than expected).

Fields of papers citing papers by Antonio Coluccia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Coluccia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Coluccia. The network helps show where Antonio Coluccia may publish in the future.

Co-authorship network of co-authors of Antonio Coluccia

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Coluccia. A scholar is included among the top collaborators of Antonio Coluccia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Coluccia. Antonio Coluccia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Touret, Franck, Antonio Coluccia, Carole Di Giorgio, et al.. (2025). Design and synthesis of novel thioether analogs as promising antiviral agents: In vitro activity against enteroviruses of interest. European Journal of Medicinal Chemistry. 288. 117395–117395.
2.
Masci, Domiziana, Antonio Coluccia, Maurice Santelli, et al.. (2025). Microwave-assisted synthesis of tubulin assembly inhibitors as anticancer agents by aryl ring reversal and conjunctive approach. RSC Medicinal Chemistry. 16(10). 4845–4858. 1 indexed citations
3.
Masci, Domiziana, Antonio Coluccia, Maurice Santelli, et al.. (2025). Ferroptosis Induction by a New Pyrrole Derivative in Triple Negative Breast Cancer and Colorectal Cancer. Journal of Medicinal Chemistry. 68(16). 17840–17858. 1 indexed citations
4.
Scoffone, Viola Camilla, Gabriele Trespidi, Giulia Barbieri, et al.. (2025). Identification of a New FtsZ Inhibitor by Virtual Screening, Mechanistic Insights, and Structure–Activity Relationship Analyses. ACS Infectious Diseases. 11(4). 998–1007. 1 indexed citations
5.
Consalvi, Sara, Mariangela Biava, Alessia Ciogli, et al.. (2024). SAR Analysis of Novel Coxsackie virus A9 Capsid Binders. Journal of Medicinal Chemistry. 67(19). 17144–17161.
6.
Touret, Franck, Antonio Coluccia, Omar Khoumeri, et al.. (2024). New potent EV-A71 antivirals targeting capsid. European Journal of Medicinal Chemistry. 276. 116658–116658. 1 indexed citations
7.
Nalli, Marianna, Giuseppe La Regina, Angelo Toto, et al.. (2023). Targeting the Grb2 cSH3 domain: Design, synthesis and biological evaluation of the first series of modulators. Bioorganic Chemistry. 138. 106607–106607. 3 indexed citations
8.
Magno, Laura Di, Antonio Coluccia, Giuseppe La Regina, et al.. (2022). Discovery of novel human lactate dehydrogenase inhibitors: Structure-based virtual screening studies and biological assessment. European Journal of Medicinal Chemistry. 240. 114605–114605. 19 indexed citations
9.
Laudette, Marion, Jean‐Paul Blondeau, Frank Lezoualc’h, et al.. (2020). Modeling Epac1 interactions with the allosteric inhibitor AM-001 by co-solvent molecular dynamics. Journal of Computer-Aided Molecular Design. 34(11). 1171–1179. 3 indexed citations
10.
Nalli, Marianna, Domiziana Masci, Antonio Coluccia, et al.. (2020). New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strains. European Journal of Medicinal Chemistry. 208. 112696–112696. 12 indexed citations
11.
Regina, Giuseppe La, et al.. (2019). Towards modern anticancer agents that interact with tubulin. European Journal of Pharmaceutical Sciences. 131. 58–68. 39 indexed citations
12.
Masci, Domiziana, Charlotte K. Hind, Anita Toscani, et al.. (2019). Switching on the activity of 1,5-diaryl-pyrrole derivatives against drug-resistant ESKAPE bacteria: Structure-activity relationships and mode of action studies. European Journal of Medicinal Chemistry. 178. 500–514. 26 indexed citations
13.
Roche, Manon, Antonio Coluccia, Johan Neyts, et al.. (2016). VP1 crystal structure-guided exploration and optimization of 4,5-dimethoxybenzene-based inhibitors of rhinovirus 14 infection. European Journal of Medicinal Chemistry. 115. 453–462. 7 indexed citations
14.
Massarotti, Alberto & Antonio Coluccia. (2015). An in-silico approach aimed to clarify the role of Y181C and K103N HIV-1 reverse transcriptase mutations versus Indole Aryl Sulphones. Journal of Molecular Graphics and Modelling. 63. 49–56. 5 indexed citations
15.
Manvar, Dinesh, Sveva Pelliccia, Giuseppe La Regina, et al.. (2014). New 1-phenyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides inhibit hepatitis C virus replication via suppression of cyclooxygenase-2. European Journal of Medicinal Chemistry. 90. 497–506. 22 indexed citations
16.
Famiglini, Valeria, Giuseppe La Regina, Antonio Coluccia, et al.. (2014). New indolylarylsulfones as highly potent and broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitors. European Journal of Medicinal Chemistry. 80. 101–111. 23 indexed citations
17.
Mead, Richard J., Adrian Higginbottom, Scott P. Allen, et al.. (2013). S[+] Apomorphine is a CNS penetrating activator of the Nrf2-ARE pathway with activity in mouse and patient fibroblast models of amyotrophic lateral sclerosis. Free Radical Biology and Medicine. 61. 438–452. 55 indexed citations
18.
Massarotti, Alberto, Antonio Coluccia, Romano Silvestri, Giovanni Sorba, & Andrea Brancale. (2011). The Tubulin Colchicine Domain: a Molecular Modeling Perspective. ChemMedChem. 7(1). 33–42. 144 indexed citations
19.
Massarotti, Alberto, Antonio Coluccia, Giovanni Sorba, Romano Silvestri, & Andrea Brancale. (2011). De novo computer-aided design of novel antiviral agents. Drug Discovery Today Technologies. 9(3). e213–e218. 2 indexed citations
20.
Ragno, Rino, Antonio Coluccia, Giuseppe La Regina, & Romano Silvestri. (2007). Indolyl aryl sulphones as HIV-1 reverse transcriptase inhibitors: docking and 3D QSAR studies. Expert Opinion on Drug Discovery. 2(1). 87–114. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026